Cargando…
Gastrointestinal sequelae 90 days after discharge for COVID-19
Autores principales: | Weng, Jingrong, Li, Yichen, Li, Jie, Shen, Lihan, Zhu, Lixin, Liang, Yufan, Lin, Xutao, Jiao, Na, Cheng, Sijing, Huang, Yibo, Zou, Yifeng, Yan, Guangjun, Zhu, Ruixin, Lan, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943402/ https://www.ncbi.nlm.nih.gov/pubmed/33711290 http://dx.doi.org/10.1016/S2468-1253(21)00076-5 |
Ejemplares similares
-
Adverse Outcomes Associated With Corticosteroid Use in Critical COVID-19: A Retrospective Multicenter Cohort Study
por: Li, Yichen, et al.
Publicado: (2021) -
Correlation between altered gut microbiota and elevated inflammation markers in patients with Crohn’s disease
por: Hu, Jun, et al.
Publicado: (2022) -
Enteric involvement in hospitalised patients with COVID-19 outside Wuhan
por: Wan, Yunle, et al.
Publicado: (2020) -
Risk factors for the critical illness in SARS-CoV-2 infection: a multicenter retrospective cohort study
por: Cheng, Sijing, et al.
Publicado: (2020) -
The Proinflammatory Role of Guanylate-Binding Protein 5 in Inflammatory Bowel Diseases
por: Li, Yichen, et al.
Publicado: (2022)